Overview

• U.S. kefir supplier's Q4 net sales rose 18% yr/yr, driven by volume-led growth

• Company reported Q4 net income of $2.5 mln, reversing prior-year loss

• Q4 gross margin expanded by 250 basis points, reflecting operational execution

Outlook

• Company reiterates long-term target of $45–$50 mln Adjusted EBITDA for FY 2027

• Lifeway expects to deliver strongest annual sales in company history in FY 2026

• Company says investments in capacity, marketing and innovation to drive future growth

Result Drivers

• MARKETING INVESTMENT - Co said continued investment in marketing and brand awareness contributed to sales growth and increased consumer engagement

• PRODUCT INNOVATION - New product launches, including Lifeway Kefir Butter and Muscle Mates, expanded the portfolio and addressed evolving consumer tastes

• OPERATIONAL EXECUTION - Disciplined execution drove significant gross margin expansion and net income growth, per CEO Julie Smolyansky

Company press release: ID:nPn4qlNVfa

Key Details

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the food processing peer group is "buy"

• Wall Street's median 12-month price target for Lifeway Foods Inc is $34.00, about 64.2% above its March 16 closing price of $20.71

• The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 20 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)